I
Ingela Turesson
Researcher at Uppsala University
Publications - 30
Citations - 6343
Ingela Turesson is an academic researcher from Uppsala University. The author has contributed to research in topics: Radiation therapy & Prostate cancer. The author has an hindex of 16, co-authored 29 publications receiving 6051 citations.
Papers
More filters
Journal ArticleDOI
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Ian F. Tannock,Ronald de Wit,William R. Berry,Jozsef Horti,Anna Pluzanska,Kim N. Chi,Stéphane Oudard,Christine Theodore,Nicholas D. James,Ingela Turesson,Mark Rosenthal,Mario A. Eisenberger +11 more
TL;DR: When given with prednisone, treatment with docetaxel every three weeks led to superior survival and improved rates of response in terms of pain, serum PSA level, and quality of life, as compared with mitoxantrone plusprednisone.
Journal ArticleDOI
p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis.
TL;DR: Results implicate p38 in organization of new vessels and suggest that p38 is an essential regulator of FGF-2–driven angiogenesis, which is suggested to be an essential regulation of growth factor–dependent cellular functions.
Journal ArticleDOI
The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules
TL;DR: The initial results of a study aimed at establishing whether a direct relationship exists between cellular radiosensitivity and tissue response suggest that cellular sensitivity might form the basis for the development of an assay system capable of predicting late normal tissue effects to curative radiotherapy, which might allow dose escalation in some patients.
Journal ArticleDOI
DNA double strand break quantification in skin biopsies.
TL;DR: A method to measure the relative amount of DNA double strand breaks by detecting gamma H2AX foci in patients exposed to radiotherapy is established and has the potential to predict individual radiosensitivity.
Journal ArticleDOI
Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity
TL;DR: It is hoped that the definitions and terminology proposed here will aid communication in the field of predictive testing of normal tissue radiosensitivity, as well as a simple terminology for describing normal tissue reactions in patients having radiotherapy.